Some individuals may achieve their weight loss goals at lower doses, while others might require higher doses for sustained results
So, there is a complex hormonal and metabolic effect of obesity, weight alterations, age and hormones that play a role in the acne development of women on these medications that needs more research. According to the authors interpretation of previous studies taken with their findings, the hyperandrogenic state of women with obesity may heighten their response to GLP-1 receptor agonists
As a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, tirzepatide works by targeting multiple pathways involved in appetite regulation and glucose metabolism
While some people pay for these medications out of pocket, the majority of the costs are borne by insurance companies, employers, or other third-party payers
Descriptive statistics (mean s.e.m.) were used to summarize the results
Sources FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
